INTEGRATED BIOPHARMA INC FY 2026: Revenue $43.87M, EPS ($0.09) — 10-K Summary

Integrated Biopharma Inc reported fiscal 2026 results with revenue of $43.87M, down from $54.35M a year earlier, producing a net loss of ($2.84M) and diluted EPS of ($0.09) — a year-over-year decline versus FY 2025 — according to its 10-K filing.Financial Highlights¹ Reported as “Sales, net”. ² Rep…